The Institute of Bioorganic Chemistry offers consumers a test system for early diagnosis of pancreatitis under a manufacturing agreement and is looking for partners to sell technology for obtaining test systems to conclude a license agreement and a distribution service agreement.

A set of reagents "FLA2-FOA" for determining the activity of pancreatic phospholipase A2 in human blood by the method of photometric analysis.

An original technology has been developed that allows, based on the results of preclinical and clinical trials, the use of a test system for determining the activity of PLA2 developed on its basis, which is implemented using the created set of reagents "FLA2-FOA", in clinical and laboratory practice in the process of differential diagnosis of severe forms of necrotizing pancreatitis as an informative laboratory biochemical test.

Registration certificate for industrial production IM-7.103513 dated 30.11.2015.

Production is organized jointly with a unitary enterprise
"Self-supporting pilot production of the Institute of Bioorganic Chemistry
NAS of Belarus ".

Patents of the Republic of Belarus: No. 12552 "Method for determining the activity of phospholipase A2 in blood serum", No. 13143 "Method for diagnosing pancreatitis by level A2 of phospholipase activity in blood serum".

A significant amount of fundamental research is carried out under grants from the Belarusian Republican Foundation for Basic Research, including with the participation of international partners - organizations from Russia, the Czech Republic, etc.

Consumer test system for early diagnosis of pancreatitis as part of a manufacturing agreement.
Partners for the sale of technology for obtaining test systems for early diagnosis of pancreatitis under a license agreement and a distribution service agreement.